世界の循環腫瘍細胞（CTC）診断市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Circulating Tumor Cell (CTC) Diagnostics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1337 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、130ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、循環腫瘍細胞（CTC）診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（CTC濃縮、CTC検出）、用途別市場規模（病院・クリニック、製薬・バイオテクノロジー企業、学術研究機関、CRO）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・循環腫瘍細胞（CTC）診断の市場動向 ・企業の競争状況、市場シェア ・循環腫瘍細胞（CTC）診断の種類別市場規模（CTC濃縮、CTC検出） ・循環腫瘍細胞（CTC）診断の用途別市場規模（病院・クリニック、製薬・バイオテクノロジー企業、学術研究機関、CRO） ・循環腫瘍細胞（CTC）診断の北米市場規模2016-2027（アメリカ、カナダ） ・循環腫瘍細胞（CTC）診断のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・循環腫瘍細胞（CTC）診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・循環腫瘍細胞（CTC）診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・循環腫瘍細胞（CTC）診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（ApoCell, Inc.(US)、Biocep Ltd. (Israel)、Biocept, Inc.(US)、Biofluidica MicrotechnologiesLLc(US)、Celltraffix Inc.(US)、ClearbridgeBiomedics(Singapore)、Creatv Microtech, Inc.(US)、CynvenioBiosystems, Inc.(US)、EpicBiosciencesInc.(US)、FluxionBiosciences, Inc.(US)、Ikonisys, Inc.(US)、IVDiagnostics, Inc.(US)、JanssenDiagnosticsLLc(US)、QIAGEnHannoverGmbH (Germany)、RARECELLsSAs(Italy)、ScreenCell(France)、STEMCELlTechnologies, Inc.(Canada)） ・結論

Circulatingtumorcells(CTCs)arecellsthathaveshed intothevasculatureorlymphaticsfrom a primarytumorand arecarried around thebodyintheblood circulation.

Market Analysis and Insights: Global Circulating Tumor Cell (CTC) Diagnostics Market
The global Circulating Tumor Cell (CTC) Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Circulating Tumor Cell (CTC) Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Circulating Tumor Cell (CTC) Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Circulating Tumor Cell (CTC) Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Circulating Tumor Cell (CTC) Diagnostics market.

Global Circulating Tumor Cell (CTC) Diagnostics Scope and Market Size
Circulating Tumor Cell (CTC) Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Circulating Tumor Cell (CTC) Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
CTC Enrichment
CTC Detection

Segment by Application
Hospitals and clinics
Pharmaceuticals and biotechnology companies
Academic research institutes
CROs

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
ApoCell, Inc.(US)
Biocep Ltd. (Israel)
Biocept, Inc.(US)
Biofluidica MicrotechnologiesLLc(US)
Celltraffix Inc.(US)
ClearbridgeBiomedics(Singapore)
Creatv Microtech, Inc.(US)
CynvenioBiosystems, Inc.(US)
EpicBiosciencesInc.(US)
Biofluidica MicrotechnologiesLLc(US)
Celltraffix Inc.(US)
IVDiagnostics, Inc.(US)
JanssenDiagnosticsLLc(US)
QIAGEnHannoverGmbH (Germany)
RARECELLsSAs(Italy)

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Circulating Tumor Cell (CTC) Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 CTC Enrichment
1.2.3 CTC Detection
1.3 Market by Application
1.3.1 Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals and clinics
1.3.3 Pharmaceuticals and biotechnology companies
1.3.4 Academic research institutes
1.3.5 CROs
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Circulating Tumor Cell (CTC) Diagnostics Market Perspective (2016-2027)
2.2 Circulating Tumor Cell (CTC) Diagnostics Growth Trends by Regions
2.2.1 Circulating Tumor Cell (CTC) Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Circulating Tumor Cell (CTC) Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Circulating Tumor Cell (CTC) Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Circulating Tumor Cell (CTC) Diagnostics Industry Dynamic
2.3.1 Circulating Tumor Cell (CTC) Diagnostics Market Trends
2.3.2 Circulating Tumor Cell (CTC) Diagnostics Market Drivers
2.3.3 Circulating Tumor Cell (CTC) Diagnostics Market Challenges
2.3.4 Circulating Tumor Cell (CTC) Diagnostics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Circulating Tumor Cell (CTC) Diagnostics Players by Revenue
3.1.1 Global Top Circulating Tumor Cell (CTC) Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Circulating Tumor Cell (CTC) Diagnostics Revenue
3.4 Global Circulating Tumor Cell (CTC) Diagnostics Market Concentration Ratio
3.4.1 Global Circulating Tumor Cell (CTC) Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Circulating Tumor Cell (CTC) Diagnostics Revenue in 2020
3.5 Circulating Tumor Cell (CTC) Diagnostics Key Players Head office and Area Served
3.6 Key Players Circulating Tumor Cell (CTC) Diagnostics Product Solution and Service
3.7 Date of Enter into Circulating Tumor Cell (CTC) Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Circulating Tumor Cell (CTC) Diagnostics Breakdown Data by Type
4.1 Global Circulating Tumor Cell (CTC) Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Circulating Tumor Cell (CTC) Diagnostics Forecasted Market Size by Type (2022-2027)

5 Circulating Tumor Cell (CTC) Diagnostics Breakdown Data by Application
5.1 Global Circulating Tumor Cell (CTC) Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Circulating Tumor Cell (CTC) Diagnostics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Circulating Tumor Cell (CTC) Diagnostics Market Size (2016-2027)
6.2 North America Circulating Tumor Cell (CTC) Diagnostics Market Size by Type
6.2.1 North America Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2016-2027)
6.3 North America Circulating Tumor Cell (CTC) Diagnostics Market Size by Application
6.3.1 North America Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2016-2027)
6.4 North America Circulating Tumor Cell (CTC) Diagnostics Market Size by Country
6.4.1 North America Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Circulating Tumor Cell (CTC) Diagnostics Market Size (2016-2027)
7.2 Europe Circulating Tumor Cell (CTC) Diagnostics Market Size by Type
7.2.1 Europe Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2016-2027)
7.3 Europe Circulating Tumor Cell (CTC) Diagnostics Market Size by Application
7.3.1 Europe Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2016-2027)
7.4 Europe Circulating Tumor Cell (CTC) Diagnostics Market Size by Country
7.4.1 Europe Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Size by Type
8.2.1 Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Size by Application
8.3.1 Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Size by Region
8.4.1 Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Circulating Tumor Cell (CTC) Diagnostics Market Size (2016-2027)
9.2 Latin America Circulating Tumor Cell (CTC) Diagnostics Market Size by Type
9.2.1 Latin America Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Circulating Tumor Cell (CTC) Diagnostics Market Size by Application
9.3.1 Latin America Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Circulating Tumor Cell (CTC) Diagnostics Market Size by Country
9.4.1 Latin America Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Size by Type
10.2.1 Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Size by Application
10.3.1 Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Size by Country
10.4.1 Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 ApoCell, Inc.(US)
11.1.1 ApoCell, Inc.(US) Company Details
11.1.2 ApoCell, Inc.(US) Business Overview
11.1.3 ApoCell, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.1.4 ApoCell, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021)
11.1.5 ApoCell, Inc.(US) Recent Development
11.2 Biocep Ltd. (Israel)
11.2.1 Biocep Ltd. (Israel) Company Details
11.2.2 Biocep Ltd. (Israel) Business Overview
11.2.3 Biocep Ltd. (Israel) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.2.4 Biocep Ltd. (Israel) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021)
11.2.5 Biocep Ltd. (Israel) Recent Development
11.3 Biocept, Inc.(US)
11.3.1 Biocept, Inc.(US) Company Details
11.3.2 Biocept, Inc.(US) Business Overview
11.3.3 Biocept, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.3.4 Biocept, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021)
11.3.5 Biocept, Inc.(US) Recent Development
11.4 Biofluidica MicrotechnologiesLLc(US)
11.4.1 Biofluidica MicrotechnologiesLLc(US) Company Details
11.4.2 Biofluidica MicrotechnologiesLLc(US) Business Overview
11.4.3 Biofluidica MicrotechnologiesLLc(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.4.4 Biofluidica MicrotechnologiesLLc(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021)
11.4.5 Biofluidica MicrotechnologiesLLc(US) Recent Development
11.5 Celltraffix Inc.(US)
11.5.1 Celltraffix Inc.(US) Company Details
11.5.2 Celltraffix Inc.(US) Business Overview
11.5.3 Celltraffix Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.5.4 Celltraffix Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021)
11.5.5 Celltraffix Inc.(US) Recent Development
11.6 ClearbridgeBiomedics(Singapore)
11.6.1 ClearbridgeBiomedics(Singapore) Company Details
11.6.2 ClearbridgeBiomedics(Singapore) Business Overview
11.6.3 ClearbridgeBiomedics(Singapore) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.6.4 ClearbridgeBiomedics(Singapore) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021)
11.6.5 ClearbridgeBiomedics(Singapore) Recent Development
11.7 Creatv Microtech, Inc.(US)
11.7.1 Creatv Microtech, Inc.(US) Company Details
11.7.2 Creatv Microtech, Inc.(US) Business Overview
11.7.3 Creatv Microtech, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.7.4 Creatv Microtech, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021)
11.7.5 Creatv Microtech, Inc.(US) Recent Development
11.8 CynvenioBiosystems, Inc.(US)
11.8.1 CynvenioBiosystems, Inc.(US) Company Details
11.8.2 CynvenioBiosystems, Inc.(US) Business Overview
11.8.3 CynvenioBiosystems, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.8.4 CynvenioBiosystems, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021)
11.8.5 CynvenioBiosystems, Inc.(US) Recent Development
11.9 EpicBiosciencesInc.(US)
11.9.1 EpicBiosciencesInc.(US) Company Details
11.9.2 EpicBiosciencesInc.(US) Business Overview
11.9.3 EpicBiosciencesInc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.9.4 EpicBiosciencesInc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021)
11.9.5 EpicBiosciencesInc.(US) Recent Development
11.10 FluxionBiosciences, Inc.(US)
11.10.1 FluxionBiosciences, Inc.(US) Company Details
11.10.2 FluxionBiosciences, Inc.(US) Business Overview
11.10.3 FluxionBiosciences, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.10.4 FluxionBiosciences, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021)
11.10.5 FluxionBiosciences, Inc.(US) Recent Development
11.11 Ikonisys, Inc.(US)
11.11.1 Ikonisys, Inc.(US) Company Details
11.11.2 Ikonisys, Inc.(US) Business Overview
11.11.3 Ikonisys, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.11.4 Ikonisys, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021)
11.11.5 Ikonisys, Inc.(US) Recent Development
11.12 IVDiagnostics, Inc.(US)
11.12.1 IVDiagnostics, Inc.(US) Company Details
11.12.2 IVDiagnostics, Inc.(US) Business Overview
11.12.3 IVDiagnostics, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.12.4 IVDiagnostics, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021)
11.12.5 IVDiagnostics, Inc.(US) Recent Development
11.13 JanssenDiagnosticsLLc(US)
11.13.1 JanssenDiagnosticsLLc(US) Company Details
11.13.2 JanssenDiagnosticsLLc(US) Business Overview
11.13.3 JanssenDiagnosticsLLc(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.13.4 JanssenDiagnosticsLLc(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021)
11.13.5 JanssenDiagnosticsLLc(US) Recent Development
11.14 QIAGEnHannoverGmbH (Germany)
11.14.1 QIAGEnHannoverGmbH (Germany) Company Details
11.14.2 QIAGEnHannoverGmbH (Germany) Business Overview
11.14.3 QIAGEnHannoverGmbH (Germany) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.14.4 QIAGEnHannoverGmbH (Germany) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021)
11.14.5 QIAGEnHannoverGmbH (Germany) Recent Development
11.15 RARECELLsSAs(Italy)
11.15.1 RARECELLsSAs(Italy) Company Details
11.15.2 RARECELLsSAs(Italy) Business Overview
11.15.3 RARECELLsSAs(Italy) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.15.4 RARECELLsSAs(Italy) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021)
11.15.5 RARECELLsSAs(Italy) Recent Development
11.16 ScreenCell(France)
11.16.1 ScreenCell(France) Company Details
11.16.2 ScreenCell(France) Business Overview
11.16.3 ScreenCell(France) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.16.4 ScreenCell(France) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021)
11.16.5 ScreenCell(France) Recent Development
11.17 STEMCELlTechnologies, Inc.(Canada)
11.17.1 STEMCELlTechnologies, Inc.(Canada) Company Details
11.17.2 STEMCELlTechnologies, Inc.(Canada) Business Overview
11.17.3 STEMCELlTechnologies, Inc.(Canada) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.17.4 STEMCELlTechnologies, Inc.(Canada) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021)
11.17.5 STEMCELlTechnologies, Inc.(Canada) Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Circulating Tumor Cell (CTC) Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of CTC Enrichment
Table 3. Key Players of CTC Detection
Table 4. Global Circulating Tumor Cell (CTC) Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Circulating Tumor Cell (CTC) Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Circulating Tumor Cell (CTC) Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Regions (2016-2021)
Table 8. Global Circulating Tumor Cell (CTC) Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Regions (2022-2027)
Table 10. Circulating Tumor Cell (CTC) Diagnostics Market Trends
Table 11. Circulating Tumor Cell (CTC) Diagnostics Market Drivers
Table 12. Circulating Tumor Cell (CTC) Diagnostics Market Challenges
Table 13. Circulating Tumor Cell (CTC) Diagnostics Market Restraints
Table 14. Global Circulating Tumor Cell (CTC) Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Players (2016-2021)
Table 16. Global Top Circulating Tumor Cell (CTC) Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Circulating Tumor Cell (CTC) Diagnostics as of 2020)
Table 17. Ranking of Global Top Circulating Tumor Cell (CTC) Diagnostics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Circulating Tumor Cell (CTC) Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Circulating Tumor Cell (CTC) Diagnostics Product Solution and Service
Table 21. Date of Enter into Circulating Tumor Cell (CTC) Diagnostics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Type (2016-2021)
Table 25. Global Circulating Tumor Cell (CTC) Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Circulating Tumor Cell (CTC) Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Application (2016-2021)
Table 29. Global Circulating Tumor Cell (CTC) Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 61. ApoCell, Inc.(US) Company Details
Table 62. ApoCell, Inc.(US) Business Overview
Table 63. ApoCell, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product
Table 64. ApoCell, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021) & (US$ Million)
Table 65. ApoCell, Inc.(US) Recent Development
Table 66. Biocep Ltd. (Israel) Company Details
Table 67. Biocep Ltd. (Israel) Business Overview
Table 68. Biocep Ltd. (Israel) Circulating Tumor Cell (CTC) Diagnostics Product
Table 69. Biocep Ltd. (Israel) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021) & (US$ Million)
Table 70. Biocep Ltd. (Israel) Recent Development
Table 71. Biocept, Inc.(US) Company Details
Table 72. Biocept, Inc.(US) Business Overview
Table 73. Biocept, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product
Table 74. Biocept, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021) & (US$ Million)
Table 75. Biocept, Inc.(US) Recent Development
Table 76. Biofluidica MicrotechnologiesLLc(US) Company Details
Table 77. Biofluidica MicrotechnologiesLLc(US) Business Overview
Table 78. Biofluidica MicrotechnologiesLLc(US) Circulating Tumor Cell (CTC) Diagnostics Product
Table 79. Biofluidica MicrotechnologiesLLc(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021) & (US$ Million)
Table 80. Biofluidica MicrotechnologiesLLc(US) Recent Development
Table 81. Celltraffix Inc.(US) Company Details
Table 82. Celltraffix Inc.(US) Business Overview
Table 83. Celltraffix Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product
Table 84. Celltraffix Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021) & (US$ Million)
Table 85. Celltraffix Inc.(US) Recent Development
Table 86. ClearbridgeBiomedics(Singapore) Company Details
Table 87. ClearbridgeBiomedics(Singapore) Business Overview
Table 88. ClearbridgeBiomedics(Singapore) Circulating Tumor Cell (CTC) Diagnostics Product
Table 89. ClearbridgeBiomedics(Singapore) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021) & (US$ Million)
Table 90. ClearbridgeBiomedics(Singapore) Recent Development
Table 91. Creatv Microtech, Inc.(US) Company Details
Table 92. Creatv Microtech, Inc.(US) Business Overview
Table 93. Creatv Microtech, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product
Table 94. Creatv Microtech, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021) & (US$ Million)
Table 95. Creatv Microtech, Inc.(US) Recent Development
Table 96. CynvenioBiosystems, Inc.(US) Company Details
Table 97. CynvenioBiosystems, Inc.(US) Business Overview
Table 98. CynvenioBiosystems, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021) & (US$ Million)
Table 99. CynvenioBiosystems, Inc.(US) Recent Development
Table 100. EpicBiosciencesInc.(US) Company Details
Table 101. EpicBiosciencesInc.(US) Business Overview
Table 102. EpicBiosciencesInc.(US) Circulating Tumor Cell (CTC) Diagnostics Product
Table 103. EpicBiosciencesInc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021) & (US$ Million)
Table 104. EpicBiosciencesInc.(US) Recent Development
Table 105. FluxionBiosciences, Inc.(US) Company Details
Table 106. FluxionBiosciences, Inc.(US) Business Overview
Table 107. FluxionBiosciences, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product
Table 108. FluxionBiosciences, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021) & (US$ Million)
Table 109. FluxionBiosciences, Inc.(US) Recent Development
Table 110. Ikonisys, Inc.(US) Company Details
Table 111. Ikonisys, Inc.(US) Business Overview
Table 112. Ikonisys, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product
Table 113. Ikonisys, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021) & (US$ Million)
Table 114. Ikonisys, Inc.(US) Recent Development
Table 115. IVDiagnostics, Inc.(US) Company Details
Table 116. IVDiagnostics, Inc.(US) Business Overview
Table 117. IVDiagnostics, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product
Table 118. IVDiagnostics, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021) & (US$ Million)
Table 119. IVDiagnostics, Inc.(US) Recent Development
Table 120. JanssenDiagnosticsLLc(US) Company Details
Table 121. JanssenDiagnosticsLLc(US) Business Overview
Table 122. JanssenDiagnosticsLLc(US) Circulating Tumor Cell (CTC) Diagnostics Product
Table 123. JanssenDiagnosticsLLc(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021) & (US$ Million)
Table 124. JanssenDiagnosticsLLc(US) Recent Development
Table 125. QIAGEnHannoverGmbH (Germany) Company Details
Table 126. QIAGEnHannoverGmbH (Germany) Business Overview
Table 127. QIAGEnHannoverGmbH (Germany) Circulating Tumor Cell (CTC) Diagnostics Product
Table 128. QIAGEnHannoverGmbH (Germany) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021) & (US$ Million)
Table 129. QIAGEnHannoverGmbH (Germany) Recent Development
Table 130. RARECELLsSAs(Italy) Company Details
Table 131. RARECELLsSAs(Italy) Business Overview
Table 132. RARECELLsSAs(Italy) Circulating Tumor Cell (CTC) Diagnostics Product
Table 133. RARECELLsSAs(Italy) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021) & (US$ Million)
Table 134. RARECELLsSAs(Italy) Recent Development
Table 135. ScreenCell(France) Company Details
Table 136. ScreenCell(France) Business Overview
Table 137. ScreenCell(France) Circulating Tumor Cell (CTC) Diagnostics Product
Table 138. ScreenCell(France) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021) & (US$ Million)
Table 139. ScreenCell(France) Recent Development
Table 140. STEMCELlTechnologies, Inc.(Canada) Company Details
Table 141. STEMCELlTechnologies, Inc.(Canada) Business Overview
Table 142. STEMCELlTechnologies, Inc.(Canada) Circulating Tumor Cell (CTC) Diagnostics Product
Table 143. STEMCELlTechnologies, Inc.(Canada) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021) & (US$ Million)
Table 144. STEMCELlTechnologies, Inc.(Canada) Recent Development
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. CTC Enrichment Features
Figure 3. CTC Detection Features
Figure 4. Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Application: 2020 VS 2027
Figure 5. Hospitals and clinics Case Studies
Figure 6. Pharmaceuticals and biotechnology companies Case Studies
Figure 7. Academic research institutes Case Studies
Figure 8. CROs Case Studies
Figure 9. Circulating Tumor Cell (CTC) Diagnostics Report Years Considered
Figure 10. Global Circulating Tumor Cell (CTC) Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Circulating Tumor Cell (CTC) Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Regions: 2020 VS 2027
Figure 13. Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Regions (2022-2027)
Figure 14. Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Players in 2020
Figure 15. Global Top Circulating Tumor Cell (CTC) Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Circulating Tumor Cell (CTC) Diagnostics as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Circulating Tumor Cell (CTC) Diagnostics Revenue in 2020
Figure 17. Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Type (2016-2021)
Figure 18. Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Type (2022-2027)
Figure 19. North America Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Circulating Tumor Cell (CTC) Diagnostics Market Share by Type (2016-2027)
Figure 21. North America Circulating Tumor Cell (CTC) Diagnostics Market Share by Application (2016-2027)
Figure 22. North America Circulating Tumor Cell (CTC) Diagnostics Market Share by Country (2016-2027)
Figure 23. United States Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Circulating Tumor Cell (CTC) Diagnostics Market Share by Type (2016-2027)
Figure 27. Europe Circulating Tumor Cell (CTC) Diagnostics Market Share by Application (2016-2027)
Figure 28. Europe Circulating Tumor Cell (CTC) Diagnostics Market Share by Country (2016-2027)
Figure 29. Germany Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Share by Region (2016-2027)
Figure 39. China Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Circulating Tumor Cell (CTC) Diagnostics Market Share by Type (2016-2027)
Figure 47. Latin America Circulating Tumor Cell (CTC) Diagnostics Market Share by Application (2016-2027)
Figure 48. Latin America Circulating Tumor Cell (CTC) Diagnostics Market Share by Country (2016-2027)
Figure 49. Mexico Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Share by Country (2016-2027)
Figure 55. Turkey Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. ApoCell, Inc.(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021)
Figure 59. Biocep Ltd. (Israel) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021)
Figure 60. Biocept, Inc.(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021)
Figure 61. Biofluidica MicrotechnologiesLLc(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021)
Figure 62. Celltraffix Inc.(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021)
Figure 63. ClearbridgeBiomedics(Singapore) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021)
Figure 64. Creatv Microtech, Inc.(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021)
Figure 65. CynvenioBiosystems, Inc.(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021)
Figure 66. EpicBiosciencesInc.(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021)
Figure 67. FluxionBiosciences, Inc.(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021)
Figure 68. Ikonisys, Inc.(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021)
Figure 69. IVDiagnostics, Inc.(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021)
Figure 70. JanssenDiagnosticsLLc(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021)
Figure 71. QIAGEnHannoverGmbH (Germany) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021)
Figure 72. RARECELLsSAs(Italy) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021)
Figure 73. ScreenCell(France) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021)
Figure 74. STEMCELlTechnologies, Inc.(Canada) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed

---